Novartis Ag ADR (NVS)

$98.82 0.84 (0.84%)

10:51 EDT NVS Stock Quote Delayed 30 Minutes

Why Is AVROBIO (AVRO) Stock Up 83% Today?

By William White, InvestorPlace Writer May 22, 2023

AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS).

3 Drug Stocks With Promising Pipelines for 2023

3 Biotech Stocks Smart Investors Should Be Buying Up Now

7 Safe Havens All Investors Should Have Exposure to in 2022

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 856,529

Day's Range $98.75 - $100.

52-Week Range $74.09 - $105.56

Dividend & Yield N/A (N/A)

NVS Stock Predictions, Articles, and Novartis Ag ADR News

From InvestorPlace
From the Web

3 Stocks That Could Rocket on Biden’s Cancer Moonshot

By Will Ashworth, InvestorPlace Contributor Sep 20, 2022

Joe Biden’s cancer moonshot gave some of the drug companies a big shot in the arm. These three stocks all are doing big things in oncology.

6 Dividend Stocks With High Yields and Low P/E Ratios

By Mark R. Hake, CFA May 23, 2022

6 Dividend stocks with high yields and low P/E ratios. These 6 dividend stocks have yields greater than 2.5% and P/E ratios lower than 16x with a positive earnings growth forecast for 2023.

3 Undervalued Stocks to Buy Before You Sell in May and Go Away

By Tezcan Gecgil, InvestorPlace Contributor May 13, 2022

If you really decide to sell in May and go away, you may miss out some profits from these undervalued stocks to buy.

7 Drug Stocks to Consider After the Viatris Plunge

By Thomas Niel, InvestorPlace Contributor Mar 10, 2022

As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.

7 Best Long-Term Stocks to Buy and Hold for the Next Decade

By Chris MacDonald, InvestorPlace Contributor Jan 13, 2022

These seven long-term stocks are among the best picks for truly long-term investors looking for companies to hold for the next decade.

AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today

By William White, InvestorPlace Writer Dec 2, 2021

Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).

7 Drug Stocks to Buy Now While They’re Still on Sale

By Chris Lau, InvestorPlace Contributor Nov 30, 2021

Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.

7 Stocks to Buy That Will Make You Rich by 2030

By Chris Lau, InvestorPlace Contributor Nov 15, 2021

Patient investors who overcome short-term distractions will get a windfall with these stocks to buy, as they're set to grow at a faster pace.

7 Biotech Stocks Entering the Golden Boom Phase

By Chris Lau, InvestorPlace Contributor Sep 28, 2021

These biotech stocks offer a more mature take on an otherwise risky sector. These companies already have successes under their belt.

3 International Stocks to Buy for Dividend Growth

By Bob Ciura, Sure Dividend Sep 8, 2021

International stocks tend to offer higher yields than their U.S.-based counterparts, and also offer geographic diversification.

15 European Dividend Aristocrats to Diversify Your Portfolio

By Derek English Jul 21, 2021

Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

IMMP Stock: The Big Patent News Boosting Immutep Today

By Robert Lakin, InvestorPlace Contributor Apr 8, 2021

IMMP stock is getting a boost in Thursday trading after European regulators gave one of its cancer antibodies a key patent.

Midday Market Update: What Stocks Are Up Today?

By William White, InvestorPlace Writer Mar 12, 2021

The stock market has some major movers as noon rolls around on Friday and InvestorPlace is looking at what stocks are up today.

7 Pharmaceutical Stocks Working on Their Next Blockbuster

By Alex Sirois Mar 12, 2021

Pharmaceutical stocks are a sector with unique success factors. One factor is developing blockbuster drugs. These 7 are close.

NLSP Stock: The Big Deal News That Has NLS Pharma Rocketing Nearly 100% Today

By William White, InvestorPlace Writer Mar 12, 2021

NLS Pharma (NLSP) stock is taking off on Friday after announcing an exclusive license agreement with Novartis (NVS) for mazindol data.

The Top 7 Pharmaceutical Stocks for the Next 10 Years

By Alex Sirois Jan 11, 2021

Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.

Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit

By Josh Enomoto, InvestorPlace Contributor Sep 18, 2020

Although it’s one of the major pharmaceuticals, Novartis didn’t directly jump into the vaccine race. That might have been the best move for Novartis stock.

This Company is the Landlord of Life Sciences

By Neil George Aug 7, 2020

Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.

5 High-Yield Drug Stocks That Are Undervalued With Great Upside

By Mark R. Hake, CFA Jul 24, 2020

As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.

Novartis Ag ADR (NVS)

Why Is AVROBIO (AVRO) Stock Up 83% Today?

3 Drug Stocks With Promising Pipelines for 2023

3 Biotech Stocks Smart Investors Should Be Buying Up Now

7 Safe Havens All Investors Should Have Exposure to in 2022

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novartis Ag ADR (NVS)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVS Stock Predictions, Articles, and Novartis Ag ADR News

Subscriber Sign in